Table I.II.
Additional select indicators reported for human health sector.
| Indicator | Yes, n (%) | Otherwise, n (%) |
|---|---|---|
| COVID-19 Impact on NAP development | 40(98) | 1(2) |
| Country has laws or regulations on prescription and sale of antimicrobials | 34(83) | 7(17) |
| for human use | ||
| Sectors involved in NAP development and implementation-human health | 41(100) | 0 (0) |
| Sectors involved in NAP development and implementation-animal Health | 40(98) | 1(2) |
| (terrestrial and aquatic) | ||
| Sectors involved in NAP development and implementation-plant health | 25(61) | 16(39) |
| Sectors involved in NAP development and implementation-food production | 21(51) | 20(49) |
| Sectors involved in NAP development and implementation-food safety | 28(68) | 13(32) |
| Sectors involved in NAP development and implementation-environment | 36(88) | 5(12) |
| Country using relevant AMC/AMU and(or) AMR data to amend national | 15(37) | 25(63) |
| strategy and(or) inform decision making, at least annually? (Human health) |